nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Ezetimibe—atherosclerosis	0.0755	0.106	CbGbCtD
Zafirlukast—ABCG2—Rosuvastatin—atherosclerosis	0.0755	0.106	CbGbCtD
Zafirlukast—ABCG2—Pravastatin—atherosclerosis	0.0686	0.0968	CbGbCtD
Zafirlukast—CYP2C8—Simvastatin—atherosclerosis	0.0374	0.0527	CbGbCtD
Zafirlukast—CYP2C8—Pravastatin—atherosclerosis	0.0366	0.0516	CbGbCtD
Zafirlukast—CYP2C8—Lovastatin—atherosclerosis	0.0366	0.0516	CbGbCtD
Zafirlukast—CYP2C19—Rosuvastatin—atherosclerosis	0.0337	0.0476	CbGbCtD
Zafirlukast—CYP2C19—Simvastatin—atherosclerosis	0.0313	0.0442	CbGbCtD
Zafirlukast—CYP2C19—Lovastatin—atherosclerosis	0.0307	0.0433	CbGbCtD
Zafirlukast—CYP2D6—Niacin—atherosclerosis	0.0301	0.0425	CbGbCtD
Zafirlukast—CYP2C9—Rosuvastatin—atherosclerosis	0.028	0.0396	CbGbCtD
Zafirlukast—CYP2C9—Simvastatin—atherosclerosis	0.0261	0.0368	CbGbCtD
Zafirlukast—CYP2C9—Lovastatin—atherosclerosis	0.0255	0.036	CbGbCtD
Zafirlukast—CYP2C9—Pravastatin—atherosclerosis	0.0255	0.036	CbGbCtD
Zafirlukast—CYP2D6—Simvastatin—atherosclerosis	0.0238	0.0336	CbGbCtD
Zafirlukast—CYP2D6—Pravastatin—atherosclerosis	0.0233	0.0329	CbGbCtD
Zafirlukast—CYP2D6—Lovastatin—atherosclerosis	0.0233	0.0329	CbGbCtD
Zafirlukast—CYP3A4—Rosuvastatin—atherosclerosis	0.0163	0.023	CbGbCtD
Zafirlukast—CYP3A4—Ezetimibe—atherosclerosis	0.0163	0.023	CbGbCtD
Zafirlukast—CYP3A4—Simvastatin—atherosclerosis	0.0152	0.0214	CbGbCtD
Zafirlukast—CYP3A4—Pravastatin—atherosclerosis	0.0148	0.0209	CbGbCtD
Zafirlukast—CYP3A4—Lovastatin—atherosclerosis	0.0148	0.0209	CbGbCtD
Zafirlukast—Raised liver function tests—Niacin—atherosclerosis	0.00325	0.0194	CcSEcCtD
Zafirlukast—Raised liver function tests—Pravastatin—atherosclerosis	0.0032	0.0191	CcSEcCtD
Zafirlukast—Upset stomach—Lovastatin—atherosclerosis	0.00267	0.0159	CcSEcCtD
Zafirlukast—Upset stomach—Simvastatin—atherosclerosis	0.0025	0.0149	CcSEcCtD
Zafirlukast—Blood disorder—Rosuvastatin—atherosclerosis	0.00247	0.0147	CcSEcCtD
Zafirlukast—Glyburide—ABCA1—atherosclerosis	0.00246	0.882	CrCbGaD
Zafirlukast—Accidental injury—Rosuvastatin—atherosclerosis	0.00233	0.0139	CcSEcCtD
Zafirlukast—Haemoptysis—Niacin—atherosclerosis	0.00203	0.0121	CcSEcCtD
Zafirlukast—Accidental injury—Lovastatin—atherosclerosis	0.00198	0.0118	CcSEcCtD
Zafirlukast—Hepatotoxicity—Niacin—atherosclerosis	0.00195	0.0116	CcSEcCtD
Zafirlukast—Vasculitis—Lovastatin—atherosclerosis	0.00179	0.0107	CcSEcCtD
Zafirlukast—Numbness—Pravastatin—atherosclerosis	0.00178	0.0106	CcSEcCtD
Zafirlukast—Vasculitis—Ezetimibe—atherosclerosis	0.00176	0.0105	CcSEcCtD
Zafirlukast—Sensory loss—Pravastatin—atherosclerosis	0.00171	0.0102	CcSEcCtD
Zafirlukast—Vasculitis—Simvastatin—atherosclerosis	0.00168	0.01	CcSEcCtD
Zafirlukast—Hepatic failure—Rosuvastatin—atherosclerosis	0.00167	0.00994	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Niacin—atherosclerosis	0.00165	0.00985	CcSEcCtD
Zafirlukast—Injury—Rosuvastatin—atherosclerosis	0.00163	0.00972	CcSEcCtD
Zafirlukast—Vasculitis—Pravastatin—atherosclerosis	0.00152	0.00904	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00145	0.00866	CcSEcCtD
Zafirlukast—Hepatic failure—Lovastatin—atherosclerosis	0.00141	0.00842	CcSEcCtD
Zafirlukast—Neuropathy—Pravastatin—atherosclerosis	0.00139	0.00828	CcSEcCtD
Zafirlukast—Hepatic failure—Ezetimibe—atherosclerosis	0.00139	0.00826	CcSEcCtD
Zafirlukast—Injury—Lovastatin—atherosclerosis	0.00138	0.00824	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00136	0.0081	CcSEcCtD
Zafirlukast—Swelling—Simvastatin—atherosclerosis	0.00135	0.00803	CcSEcCtD
Zafirlukast—Hepatic failure—Simvastatin—atherosclerosis	0.00132	0.00788	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Niacin—atherosclerosis	0.00125	0.00744	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00123	0.00733	CcSEcCtD
Zafirlukast—Hepatic failure—Pravastatin—atherosclerosis	0.0012	0.00712	CcSEcCtD
Zafirlukast—Injury—Pravastatin—atherosclerosis	0.00117	0.00697	CcSEcCtD
Zafirlukast—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00115	0.00686	CcSEcCtD
Zafirlukast—Dermatitis bullous—Niacin—atherosclerosis	0.00114	0.0068	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00113	0.00675	CcSEcCtD
Zafirlukast—Jaundice—Rosuvastatin—atherosclerosis	0.00113	0.00671	CcSEcCtD
Zafirlukast—Eosinophilia—Lovastatin—atherosclerosis	0.00109	0.00648	CcSEcCtD
Zafirlukast—Sinusitis—Rosuvastatin—atherosclerosis	0.00108	0.00646	CcSEcCtD
Zafirlukast—Eosinophilia—Ezetimibe—atherosclerosis	0.00107	0.00635	CcSEcCtD
Zafirlukast—Abdominal discomfort—Lovastatin—atherosclerosis	0.00105	0.00627	CcSEcCtD
Zafirlukast—Hepatitis—Rosuvastatin—atherosclerosis	0.00104	0.00618	CcSEcCtD
Zafirlukast—Eosinophilia—Simvastatin—atherosclerosis	0.00102	0.00606	CcSEcCtD
Zafirlukast—Liver function test abnormal—Niacin—atherosclerosis	0.00101	0.006	CcSEcCtD
Zafirlukast—Liver function test abnormal—Pravastatin—atherosclerosis	0.000992	0.00591	CcSEcCtD
Zafirlukast—Abdominal discomfort—Simvastatin—atherosclerosis	0.000984	0.00587	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000959	0.00572	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000941	0.00561	CcSEcCtD
Zafirlukast—Jaundice—Ezetimibe—atherosclerosis	0.000936	0.00558	CcSEcCtD
Zafirlukast—Eosinophilia—Pravastatin—atherosclerosis	0.000919	0.00548	CcSEcCtD
Zafirlukast—Sinusitis—Lovastatin—atherosclerosis	0.000918	0.00547	CcSEcCtD
Zafirlukast—Sinusitis—Ezetimibe—atherosclerosis	0.000901	0.00537	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000897	0.00535	CcSEcCtD
Zafirlukast—Jaundice—Simvastatin—atherosclerosis	0.000892	0.00532	CcSEcCtD
Zafirlukast—Hepatitis—Lovastatin—atherosclerosis	0.000879	0.00524	CcSEcCtD
Zafirlukast—Hepatitis—Ezetimibe—atherosclerosis	0.000862	0.00514	CcSEcCtD
Zafirlukast—Sinusitis—Simvastatin—atherosclerosis	0.000859	0.00512	CcSEcCtD
Zafirlukast—Angioedema—Rosuvastatin—atherosclerosis	0.000825	0.00492	CcSEcCtD
Zafirlukast—Hepatitis—Simvastatin—atherosclerosis	0.000822	0.0049	CcSEcCtD
Zafirlukast—Jaundice—Niacin—atherosclerosis	0.000819	0.00488	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000811	0.00484	CcSEcCtD
Zafirlukast—Jaundice—Pravastatin—atherosclerosis	0.000807	0.00481	CcSEcCtD
Zafirlukast—Sinusitis—Pravastatin—atherosclerosis	0.000776	0.00463	CcSEcCtD
Zafirlukast—Arthralgia—Rosuvastatin—atherosclerosis	0.000768	0.00458	CcSEcCtD
Zafirlukast—Myalgia—Rosuvastatin—atherosclerosis	0.000768	0.00458	CcSEcCtD
Zafirlukast—Haemoglobin—Niacin—atherosclerosis	0.000758	0.00452	CcSEcCtD
Zafirlukast—Haemorrhage—Niacin—atherosclerosis	0.000755	0.0045	CcSEcCtD
Zafirlukast—Hepatitis—Niacin—atherosclerosis	0.000755	0.0045	CcSEcCtD
Zafirlukast—Hypoaesthesia—Niacin—atherosclerosis	0.000751	0.00448	CcSEcCtD
Zafirlukast—Hepatitis—Pravastatin—atherosclerosis	0.000743	0.00443	CcSEcCtD
Zafirlukast—Back pain—Lovastatin—atherosclerosis	0.00074	0.00441	CcSEcCtD
Zafirlukast—Hypoaesthesia—Pravastatin—atherosclerosis	0.000739	0.00441	CcSEcCtD
Zafirlukast—Infection—Rosuvastatin—atherosclerosis	0.000732	0.00436	CcSEcCtD
Zafirlukast—Back pain—Ezetimibe—atherosclerosis	0.000726	0.00433	CcSEcCtD
Zafirlukast—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000721	0.0043	CcSEcCtD
Zafirlukast—Ill-defined disorder—Lovastatin—atherosclerosis	0.00071	0.00423	CcSEcCtD
Zafirlukast—Angioedema—Lovastatin—atherosclerosis	0.000699	0.00417	CcSEcCtD
Zafirlukast—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000696	0.00415	CcSEcCtD
Zafirlukast—Malaise—Lovastatin—atherosclerosis	0.00069	0.00411	CcSEcCtD
Zafirlukast—Angioedema—Ezetimibe—atherosclerosis	0.000685	0.00409	CcSEcCtD
Zafirlukast—Malaise—Ezetimibe—atherosclerosis	0.000676	0.00403	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000671	0.004	CcSEcCtD
Zafirlukast—Insomnia—Rosuvastatin—atherosclerosis	0.000666	0.00397	CcSEcCtD
Zafirlukast—Ill-defined disorder—Simvastatin—atherosclerosis	0.000664	0.00396	CcSEcCtD
Zafirlukast—Angioedema—Simvastatin—atherosclerosis	0.000654	0.0039	CcSEcCtD
Zafirlukast—Myalgia—Lovastatin—atherosclerosis	0.000651	0.00388	CcSEcCtD
Zafirlukast—Arthralgia—Lovastatin—atherosclerosis	0.000651	0.00388	CcSEcCtD
Zafirlukast—Dyspepsia—Rosuvastatin—atherosclerosis	0.000648	0.00386	CcSEcCtD
Zafirlukast—Malaise—Simvastatin—atherosclerosis	0.000645	0.00385	CcSEcCtD
Zafirlukast—Discomfort—Lovastatin—atherosclerosis	0.000643	0.00384	CcSEcCtD
Zafirlukast—Myalgia—Ezetimibe—atherosclerosis	0.000639	0.00381	CcSEcCtD
Zafirlukast—Arthralgia—Ezetimibe—atherosclerosis	0.000639	0.00381	CcSEcCtD
Zafirlukast—Discomfort—Ezetimibe—atherosclerosis	0.000631	0.00376	CcSEcCtD
Zafirlukast—Pain—Rosuvastatin—atherosclerosis	0.00063	0.00375	CcSEcCtD
Zafirlukast—Infection—Lovastatin—atherosclerosis	0.00062	0.0037	CcSEcCtD
Zafirlukast—Thrombocytopenia—Lovastatin—atherosclerosis	0.000611	0.00364	CcSEcCtD
Zafirlukast—Arthralgia—Simvastatin—atherosclerosis	0.000609	0.00363	CcSEcCtD
Zafirlukast—Myalgia—Simvastatin—atherosclerosis	0.000609	0.00363	CcSEcCtD
Zafirlukast—Infection—Ezetimibe—atherosclerosis	0.000608	0.00363	CcSEcCtD
Zafirlukast—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000607	0.00362	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000602	0.00359	CcSEcCtD
Zafirlukast—Discomfort—Simvastatin—atherosclerosis	0.000602	0.00359	CcSEcCtD
Zafirlukast—Angioedema—Niacin—atherosclerosis	0.0006	0.00358	CcSEcCtD
Zafirlukast—Ill-defined disorder—Pravastatin—atherosclerosis	0.0006	0.00358	CcSEcCtD
Zafirlukast—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000599	0.00357	CcSEcCtD
Zafirlukast—Angioedema—Pravastatin—atherosclerosis	0.000591	0.00352	CcSEcCtD
Zafirlukast—Urticaria—Rosuvastatin—atherosclerosis	0.000585	0.00349	CcSEcCtD
Zafirlukast—Oedema—Simvastatin—atherosclerosis	0.000584	0.00348	CcSEcCtD
Zafirlukast—Malaise—Pravastatin—atherosclerosis	0.000583	0.00348	CcSEcCtD
Zafirlukast—Abdominal pain—Rosuvastatin—atherosclerosis	0.000582	0.00347	CcSEcCtD
Zafirlukast—Infection—Simvastatin—atherosclerosis	0.00058	0.00346	CcSEcCtD
Zafirlukast—Thrombocytopenia—Simvastatin—atherosclerosis	0.000572	0.00341	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000569	0.00339	CcSEcCtD
Zafirlukast—Insomnia—Lovastatin—atherosclerosis	0.000565	0.00337	CcSEcCtD
Zafirlukast—Arthralgia—Niacin—atherosclerosis	0.000559	0.00333	CcSEcCtD
Zafirlukast—Myalgia—Niacin—atherosclerosis	0.000559	0.00333	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000558	0.00333	CcSEcCtD
Zafirlukast—Insomnia—Ezetimibe—atherosclerosis	0.000554	0.0033	CcSEcCtD
Zafirlukast—Myalgia—Pravastatin—atherosclerosis	0.000551	0.00328	CcSEcCtD
Zafirlukast—Arthralgia—Pravastatin—atherosclerosis	0.000551	0.00328	CcSEcCtD
Zafirlukast—Dyspepsia—Lovastatin—atherosclerosis	0.000549	0.00328	CcSEcCtD
Zafirlukast—Discomfort—Pravastatin—atherosclerosis	0.000544	0.00324	CcSEcCtD
Zafirlukast—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000543	0.00323	CcSEcCtD
Zafirlukast—Dyspepsia—Ezetimibe—atherosclerosis	0.000539	0.00321	CcSEcCtD
Zafirlukast—Fatigue—Lovastatin—atherosclerosis	0.000538	0.00321	CcSEcCtD
Zafirlukast—Oedema—Niacin—atherosclerosis	0.000536	0.0032	CcSEcCtD
Zafirlukast—Pain—Lovastatin—atherosclerosis	0.000534	0.00318	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000532	0.00317	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000529	0.00315	CcSEcCtD
Zafirlukast—Asthenia—Rosuvastatin—atherosclerosis	0.000528	0.00315	CcSEcCtD
Zafirlukast—Insomnia—Simvastatin—atherosclerosis	0.000528	0.00315	CcSEcCtD
Zafirlukast—Oedema—Pravastatin—atherosclerosis	0.000528	0.00315	CcSEcCtD
Zafirlukast—Fatigue—Ezetimibe—atherosclerosis	0.000528	0.00315	CcSEcCtD
Zafirlukast—Infection—Pravastatin—atherosclerosis	0.000524	0.00313	CcSEcCtD
Zafirlukast—Pain—Ezetimibe—atherosclerosis	0.000524	0.00312	CcSEcCtD
Zafirlukast—Pruritus—Rosuvastatin—atherosclerosis	0.000521	0.00311	CcSEcCtD
Zafirlukast—Thrombocytopenia—Pravastatin—atherosclerosis	0.000517	0.00308	CcSEcCtD
Zafirlukast—Feeling abnormal—Lovastatin—atherosclerosis	0.000514	0.00307	CcSEcCtD
Zafirlukast—Dyspepsia—Simvastatin—atherosclerosis	0.000514	0.00306	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00051	0.00304	CcSEcCtD
Zafirlukast—Feeling abnormal—Ezetimibe—atherosclerosis	0.000505	0.00301	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000504	0.003	CcSEcCtD
Zafirlukast—Diarrhoea—Rosuvastatin—atherosclerosis	0.000504	0.003	CcSEcCtD
Zafirlukast—Fatigue—Simvastatin—atherosclerosis	0.000503	0.003	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000501	0.00298	CcSEcCtD
Zafirlukast—Pain—Simvastatin—atherosclerosis	0.000499	0.00298	CcSEcCtD
Zafirlukast—Urticaria—Lovastatin—atherosclerosis	0.000496	0.00296	CcSEcCtD
Zafirlukast—Abdominal pain—Lovastatin—atherosclerosis	0.000493	0.00294	CcSEcCtD
Zafirlukast—Body temperature increased—Lovastatin—atherosclerosis	0.000493	0.00294	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000488	0.00291	CcSEcCtD
Zafirlukast—Dizziness—Rosuvastatin—atherosclerosis	0.000487	0.0029	CcSEcCtD
Zafirlukast—Urticaria—Ezetimibe—atherosclerosis	0.000486	0.0029	CcSEcCtD
Zafirlukast—Insomnia—Niacin—atherosclerosis	0.000485	0.00289	CcSEcCtD
Zafirlukast—Abdominal pain—Ezetimibe—atherosclerosis	0.000484	0.00289	CcSEcCtD
Zafirlukast—Body temperature increased—Ezetimibe—atherosclerosis	0.000484	0.00289	CcSEcCtD
Zafirlukast—Feeling abnormal—Simvastatin—atherosclerosis	0.000481	0.00287	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000481	0.00287	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000477	0.00285	CcSEcCtD
Zafirlukast—Insomnia—Pravastatin—atherosclerosis	0.000477	0.00285	CcSEcCtD
Zafirlukast—Dyspepsia—Niacin—atherosclerosis	0.000472	0.00281	CcSEcCtD
Zafirlukast—Dyspepsia—Pravastatin—atherosclerosis	0.000465	0.00277	CcSEcCtD
Zafirlukast—Rash—Rosuvastatin—atherosclerosis	0.000464	0.00277	CcSEcCtD
Zafirlukast—Dermatitis—Rosuvastatin—atherosclerosis	0.000464	0.00277	CcSEcCtD
Zafirlukast—Urticaria—Simvastatin—atherosclerosis	0.000464	0.00276	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Niacin—atherosclerosis	0.000463	0.00276	CcSEcCtD
Zafirlukast—Body temperature increased—Simvastatin—atherosclerosis	0.000462	0.00275	CcSEcCtD
Zafirlukast—Abdominal pain—Simvastatin—atherosclerosis	0.000462	0.00275	CcSEcCtD
Zafirlukast—Headache—Rosuvastatin—atherosclerosis	0.000461	0.00275	CcSEcCtD
Zafirlukast—Hypersensitivity—Lovastatin—atherosclerosis	0.00046	0.00274	CcSEcCtD
Zafirlukast—Pain—Niacin—atherosclerosis	0.000458	0.00273	CcSEcCtD
Zafirlukast—Fatigue—Pravastatin—atherosclerosis	0.000455	0.00271	CcSEcCtD
Zafirlukast—Pain—Pravastatin—atherosclerosis	0.000451	0.00269	CcSEcCtD
Zafirlukast—Hypersensitivity—Ezetimibe—atherosclerosis	0.000451	0.00269	CcSEcCtD
Zafirlukast—Asthenia—Lovastatin—atherosclerosis	0.000448	0.00267	CcSEcCtD
Zafirlukast—Pruritus—Lovastatin—atherosclerosis	0.000442	0.00263	CcSEcCtD
Zafirlukast—Asthenia—Ezetimibe—atherosclerosis	0.000439	0.00262	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Niacin—atherosclerosis	0.000438	0.00261	CcSEcCtD
Zafirlukast—Nausea—Rosuvastatin—atherosclerosis	0.000438	0.00261	CcSEcCtD
Zafirlukast—Feeling abnormal—Pravastatin—atherosclerosis	0.000435	0.00259	CcSEcCtD
Zafirlukast—Pruritus—Ezetimibe—atherosclerosis	0.000433	0.00258	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000432	0.00257	CcSEcCtD
Zafirlukast—Hypersensitivity—Simvastatin—atherosclerosis	0.00043	0.00256	CcSEcCtD
Zafirlukast—Diarrhoea—Lovastatin—atherosclerosis	0.000427	0.00255	CcSEcCtD
Zafirlukast—Urticaria—Niacin—atherosclerosis	0.000426	0.00254	CcSEcCtD
Zafirlukast—Abdominal pain—Niacin—atherosclerosis	0.000424	0.00253	CcSEcCtD
Zafirlukast—Body temperature increased—Niacin—atherosclerosis	0.000424	0.00253	CcSEcCtD
Zafirlukast—Urticaria—Pravastatin—atherosclerosis	0.000419	0.0025	CcSEcCtD
Zafirlukast—Asthenia—Simvastatin—atherosclerosis	0.000419	0.0025	CcSEcCtD
Zafirlukast—Diarrhoea—Ezetimibe—atherosclerosis	0.000419	0.0025	CcSEcCtD
Zafirlukast—Abdominal pain—Pravastatin—atherosclerosis	0.000417	0.00249	CcSEcCtD
Zafirlukast—Body temperature increased—Pravastatin—atherosclerosis	0.000417	0.00249	CcSEcCtD
Zafirlukast—Pruritus—Simvastatin—atherosclerosis	0.000413	0.00246	CcSEcCtD
Zafirlukast—Dizziness—Lovastatin—atherosclerosis	0.000413	0.00246	CcSEcCtD
Zafirlukast—Dizziness—Ezetimibe—atherosclerosis	0.000405	0.00241	CcSEcCtD
Zafirlukast—Diarrhoea—Simvastatin—atherosclerosis	0.000399	0.00238	CcSEcCtD
Zafirlukast—Vomiting—Lovastatin—atherosclerosis	0.000397	0.00237	CcSEcCtD
Zafirlukast—Hypersensitivity—Niacin—atherosclerosis	0.000395	0.00235	CcSEcCtD
Zafirlukast—Rash—Lovastatin—atherosclerosis	0.000394	0.00235	CcSEcCtD
Zafirlukast—Dermatitis—Lovastatin—atherosclerosis	0.000393	0.00234	CcSEcCtD
Zafirlukast—Headache—Lovastatin—atherosclerosis	0.000391	0.00233	CcSEcCtD
Zafirlukast—Vomiting—Ezetimibe—atherosclerosis	0.000389	0.00232	CcSEcCtD
Zafirlukast—Hypersensitivity—Pravastatin—atherosclerosis	0.000389	0.00232	CcSEcCtD
Zafirlukast—Dizziness—Simvastatin—atherosclerosis	0.000386	0.0023	CcSEcCtD
Zafirlukast—Rash—Ezetimibe—atherosclerosis	0.000386	0.0023	CcSEcCtD
Zafirlukast—Dermatitis—Ezetimibe—atherosclerosis	0.000386	0.0023	CcSEcCtD
Zafirlukast—Asthenia—Niacin—atherosclerosis	0.000385	0.00229	CcSEcCtD
Zafirlukast—Headache—Ezetimibe—atherosclerosis	0.000384	0.00229	CcSEcCtD
Zafirlukast—Pruritus—Niacin—atherosclerosis	0.000379	0.00226	CcSEcCtD
Zafirlukast—Asthenia—Pravastatin—atherosclerosis	0.000379	0.00226	CcSEcCtD
Zafirlukast—Pruritus—Pravastatin—atherosclerosis	0.000373	0.00223	CcSEcCtD
Zafirlukast—Vomiting—Simvastatin—atherosclerosis	0.000371	0.00221	CcSEcCtD
Zafirlukast—Nausea—Lovastatin—atherosclerosis	0.000371	0.00221	CcSEcCtD
Zafirlukast—Rash—Simvastatin—atherosclerosis	0.000368	0.00219	CcSEcCtD
Zafirlukast—Dermatitis—Simvastatin—atherosclerosis	0.000368	0.00219	CcSEcCtD
Zafirlukast—Diarrhoea—Niacin—atherosclerosis	0.000367	0.00219	CcSEcCtD
Zafirlukast—Headache—Simvastatin—atherosclerosis	0.000366	0.00218	CcSEcCtD
Zafirlukast—Nausea—Ezetimibe—atherosclerosis	0.000364	0.00217	CcSEcCtD
Zafirlukast—Diarrhoea—Pravastatin—atherosclerosis	0.000361	0.00215	CcSEcCtD
Zafirlukast—Dizziness—Niacin—atherosclerosis	0.000355	0.00211	CcSEcCtD
Zafirlukast—Dizziness—Pravastatin—atherosclerosis	0.000349	0.00208	CcSEcCtD
Zafirlukast—Nausea—Simvastatin—atherosclerosis	0.000347	0.00207	CcSEcCtD
Zafirlukast—Vomiting—Niacin—atherosclerosis	0.000341	0.00203	CcSEcCtD
Zafirlukast—Rash—Niacin—atherosclerosis	0.000338	0.00201	CcSEcCtD
Zafirlukast—Dermatitis—Niacin—atherosclerosis	0.000338	0.00201	CcSEcCtD
Zafirlukast—Headache—Niacin—atherosclerosis	0.000336	0.002	CcSEcCtD
Zafirlukast—Vomiting—Pravastatin—atherosclerosis	0.000336	0.002	CcSEcCtD
Zafirlukast—Rash—Pravastatin—atherosclerosis	0.000333	0.00198	CcSEcCtD
Zafirlukast—Dermatitis—Pravastatin—atherosclerosis	0.000333	0.00198	CcSEcCtD
Zafirlukast—Headache—Pravastatin—atherosclerosis	0.000331	0.00197	CcSEcCtD
Zafirlukast—Glyburide—ALB—atherosclerosis	0.000331	0.118	CrCbGaD
Zafirlukast—Nausea—Niacin—atherosclerosis	0.000318	0.0019	CcSEcCtD
Zafirlukast—Nausea—Pravastatin—atherosclerosis	0.000314	0.00187	CcSEcCtD
Zafirlukast—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.23e-05	0.000102	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.23e-05	0.000102	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.23e-05	0.000102	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.22e-05	0.000101	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.22e-05	0.000101	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.21e-05	0.000101	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ABCA1—atherosclerosis	1.21e-05	0.0001	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.21e-05	0.0001	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.2e-05	9.98e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CD36—atherosclerosis	1.2e-05	9.98e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.2e-05	9.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—LIPC—atherosclerosis	1.2e-05	9.92e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.2e-05	9.91e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—APOC3—atherosclerosis	1.19e-05	9.86e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—MTHFR—atherosclerosis	1.19e-05	9.84e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—LDLR—atherosclerosis	1.18e-05	9.8e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—LPA—atherosclerosis	1.17e-05	9.73e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.17e-05	9.7e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PPARA—atherosclerosis	1.16e-05	9.65e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CETP—atherosclerosis	1.15e-05	9.57e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—MTHFR—atherosclerosis	1.14e-05	9.45e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—BGN—atherosclerosis	1.14e-05	9.42e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.13e-05	9.37e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.13e-05	9.35e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AGT—atherosclerosis	1.13e-05	9.35e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APOA5—atherosclerosis	1.13e-05	9.33e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—FABP4—atherosclerosis	1.12e-05	9.31e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LCAT—atherosclerosis	1.12e-05	9.31e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPARA—atherosclerosis	1.12e-05	9.27e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.11e-05	9.18e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.11e-05	9.16e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—APOE—atherosclerosis	1.11e-05	9.16e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOA4—atherosclerosis	1.1e-05	9.14e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—LIPC—atherosclerosis	1.1e-05	9.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.1e-05	9.1e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CAV1—atherosclerosis	1.09e-05	9.08e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—APOC3—atherosclerosis	1.09e-05	9.07e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.09e-05	9.06e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—APOA1—atherosclerosis	1.09e-05	9.05e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.09e-05	9.05e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—LIPC—atherosclerosis	1.09e-05	9.04e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—LDLR—atherosclerosis	1.09e-05	9.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—APOC3—atherosclerosis	1.08e-05	8.99e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.08e-05	8.98e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AGT—atherosclerosis	1.08e-05	8.98e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.08e-05	8.98e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—LDLR—atherosclerosis	1.08e-05	8.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.08e-05	8.92e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.07e-05	8.88e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CETP—atherosclerosis	1.06e-05	8.8e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—APOE—atherosclerosis	1.06e-05	8.8e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.06e-05	8.8e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.06e-05	8.78e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.06e-05	8.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CETP—atherosclerosis	1.05e-05	8.73e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CAV1—atherosclerosis	1.05e-05	8.72e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—APOA1—atherosclerosis	1.05e-05	8.7e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.05e-05	8.67e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.04e-05	8.65e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.04e-05	8.64e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—HMOX1—atherosclerosis	1.03e-05	8.58e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.02e-05	8.43e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.01e-05	8.36e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1e-05	8.3e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CG—atherosclerosis	9.97e-06	8.27e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—APOB—atherosclerosis	9.91e-06	8.22e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—atherosclerosis	9.86e-06	8.17e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.82e-06	8.14e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.67e-06	8.01e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GSTM1—atherosclerosis	9.64e-06	7.99e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PPARG—atherosclerosis	9.63e-06	7.98e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—HMGCR—atherosclerosis	9.6e-06	7.96e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CG—atherosclerosis	9.58e-06	7.94e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HMGCR—atherosclerosis	9.52e-06	7.89e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	9.5e-06	7.87e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOA2—atherosclerosis	9.5e-06	7.87e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	9.5e-06	7.87e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALOX15—atherosclerosis	9.5e-06	7.87e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—LPL—atherosclerosis	9.47e-06	7.85e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—INS—atherosclerosis	9.44e-06	7.82e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.42e-06	7.81e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NAMPT—atherosclerosis	9.38e-06	7.78e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.38e-06	7.77e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.33e-06	7.73e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—LIPC—atherosclerosis	9.32e-06	7.73e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCA1—atherosclerosis	9.31e-06	7.71e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APOC3—atherosclerosis	9.27e-06	7.68e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPARG—atherosclerosis	9.25e-06	7.66e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GPX1—atherosclerosis	9.23e-06	7.65e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—LDLR—atherosclerosis	9.21e-06	7.63e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—atherosclerosis	9.1e-06	7.54e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—INS—atherosclerosis	9.07e-06	7.52e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LPA—atherosclerosis	9.06e-06	7.51e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CETP—atherosclerosis	9e-06	7.46e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CD36—atherosclerosis	8.99e-06	7.45e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—HMOX1—atherosclerosis	8.95e-06	7.41e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—BGN—atherosclerosis	8.77e-06	7.27e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOA5—atherosclerosis	8.68e-06	7.2e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—atherosclerosis	8.65e-06	7.17e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SCARB1—atherosclerosis	8.61e-06	7.14e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.59e-06	7.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—APOB—atherosclerosis	8.57e-06	7.1e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCA1—atherosclerosis	8.56e-06	7.09e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MTHFR—atherosclerosis	8.52e-06	7.06e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCA1—atherosclerosis	8.49e-06	7.03e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.39e-06	6.95e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARA—atherosclerosis	8.36e-06	6.93e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.36e-06	6.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTM1—atherosclerosis	8.33e-06	6.91e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—atherosclerosis	8.32e-06	6.89e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—NOS3—atherosclerosis	8.28e-06	6.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—LPL—atherosclerosis	8.18e-06	6.78e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HMGCR—atherosclerosis	8.14e-06	6.74e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AGT—atherosclerosis	8.1e-06	6.71e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.07e-06	6.69e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—HMOX1—atherosclerosis	7.98e-06	6.62e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GPX1—atherosclerosis	7.98e-06	6.62e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—NOS3—atherosclerosis	7.95e-06	6.59e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—APOE—atherosclerosis	7.93e-06	6.58e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CAV1—atherosclerosis	7.86e-06	6.52e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—APOA1—atherosclerosis	7.84e-06	6.5e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CD36—atherosclerosis	7.77e-06	6.44e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—APOB—atherosclerosis	7.65e-06	6.34e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—atherosclerosis	7.57e-06	6.28e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTM1—atherosclerosis	7.44e-06	6.17e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MTHFR—atherosclerosis	7.37e-06	6.11e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—HMOX1—atherosclerosis	7.34e-06	6.09e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.34e-06	6.08e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—LPL—atherosclerosis	7.3e-06	6.05e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HMOX1—atherosclerosis	7.28e-06	6.03e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—atherosclerosis	7.27e-06	6.03e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCA1—atherosclerosis	7.25e-06	6.01e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.24e-06	6e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARA—atherosclerosis	7.23e-06	5.99e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LIPC—atherosclerosis	7.2e-06	5.96e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CG—atherosclerosis	7.16e-06	5.93e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOC3—atherosclerosis	7.15e-06	5.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GPX1—atherosclerosis	7.12e-06	5.91e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LDLR—atherosclerosis	7.11e-06	5.89e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—APOB—atherosclerosis	7.03e-06	5.83e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AGT—atherosclerosis	7e-06	5.8e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—APOB—atherosclerosis	6.97e-06	5.78e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CETP—atherosclerosis	6.94e-06	5.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CD36—atherosclerosis	6.94e-06	5.75e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARG—atherosclerosis	6.91e-06	5.73e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—APOE—atherosclerosis	6.86e-06	5.68e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTM1—atherosclerosis	6.84e-06	5.67e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CAV1—atherosclerosis	6.79e-06	5.63e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTM1—atherosclerosis	6.78e-06	5.62e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—APOA1—atherosclerosis	6.78e-06	5.62e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—INS—atherosclerosis	6.78e-06	5.62e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—LPL—atherosclerosis	6.72e-06	5.57e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—LPL—atherosclerosis	6.66e-06	5.52e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.65e-06	5.51e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MTHFR—atherosclerosis	6.57e-06	5.45e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GPX1—atherosclerosis	6.55e-06	5.43e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GPX1—atherosclerosis	6.5e-06	5.38e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARA—atherosclerosis	6.45e-06	5.35e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CD36—atherosclerosis	6.38e-06	5.29e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CD36—atherosclerosis	6.33e-06	5.24e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.28e-06	5.2e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AGT—atherosclerosis	6.25e-06	5.18e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HMOX1—atherosclerosis	6.22e-06	5.16e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—atherosclerosis	6.21e-06	5.15e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CG—atherosclerosis	6.19e-06	5.13e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—APOE—atherosclerosis	6.12e-06	5.07e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CAV1—atherosclerosis	6.06e-06	5.03e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—APOA1—atherosclerosis	6.05e-06	5.02e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.05e-06	5.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MTHFR—atherosclerosis	6e-06	4.97e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARG—atherosclerosis	5.97e-06	4.95e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APOB—atherosclerosis	5.96e-06	4.94e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—NOS3—atherosclerosis	5.94e-06	4.93e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARA—atherosclerosis	5.93e-06	4.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARA—atherosclerosis	5.88e-06	4.88e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—INS—atherosclerosis	5.86e-06	4.86e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTM1—atherosclerosis	5.8e-06	4.8e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AGT—atherosclerosis	5.75e-06	4.76e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AGT—atherosclerosis	5.7e-06	4.72e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—LPL—atherosclerosis	5.69e-06	4.72e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—APOE—atherosclerosis	5.63e-06	4.67e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.6e-06	4.64e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—APOE—atherosclerosis	5.58e-06	4.63e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CAV1—atherosclerosis	5.58e-06	4.62e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—APOA1—atherosclerosis	5.57e-06	4.61e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GPX1—atherosclerosis	5.55e-06	4.6e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CAV1—atherosclerosis	5.53e-06	4.58e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CG—atherosclerosis	5.52e-06	4.58e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—APOA1—atherosclerosis	5.52e-06	4.57e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—atherosclerosis	5.44e-06	4.51e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CD36—atherosclerosis	5.41e-06	4.48e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—atherosclerosis	5.37e-06	4.45e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARG—atherosclerosis	5.33e-06	4.42e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—INS—atherosclerosis	5.23e-06	4.33e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NOS3—atherosclerosis	5.14e-06	4.26e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.12e-06	4.25e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.08e-06	4.21e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CG—atherosclerosis	5.04e-06	4.18e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARA—atherosclerosis	5.03e-06	4.17e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARG—atherosclerosis	4.9e-06	4.06e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AGT—atherosclerosis	4.87e-06	4.03e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARG—atherosclerosis	4.86e-06	4.03e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—INS—atherosclerosis	4.81e-06	3.99e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.8e-06	3.98e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—atherosclerosis	4.79e-06	3.97e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APOE—atherosclerosis	4.77e-06	3.95e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—INS—atherosclerosis	4.77e-06	3.95e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CAV1—atherosclerosis	4.73e-06	3.92e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APOA1—atherosclerosis	4.71e-06	3.91e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—atherosclerosis	4.7e-06	3.89e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOB—atherosclerosis	4.6e-06	3.81e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NOS3—atherosclerosis	4.59e-06	3.8e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.47e-06	3.71e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—atherosclerosis	4.41e-06	3.65e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LPL—atherosclerosis	4.39e-06	3.64e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—atherosclerosis	4.37e-06	3.62e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.3e-06	3.57e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GPX1—atherosclerosis	4.28e-06	3.55e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NOS3—atherosclerosis	4.22e-06	3.5e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—atherosclerosis	4.19e-06	3.48e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NOS3—atherosclerosis	4.18e-06	3.47e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CD36—atherosclerosis	4.17e-06	3.46e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARG—atherosclerosis	4.15e-06	3.44e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—INS—atherosclerosis	4.07e-06	3.38e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.95e-06	3.28e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARA—atherosclerosis	3.88e-06	3.22e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.86e-06	3.2e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.82e-06	3.17e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—atherosclerosis	3.81e-06	3.15e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AGT—atherosclerosis	3.76e-06	3.11e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—atherosclerosis	3.74e-06	3.1e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOE—atherosclerosis	3.68e-06	3.05e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—atherosclerosis	3.66e-06	3.03e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CAV1—atherosclerosis	3.65e-06	3.02e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOA1—atherosclerosis	3.64e-06	3.02e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NOS3—atherosclerosis	3.57e-06	2.96e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.32e-06	2.75e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.27e-06	2.71e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARG—atherosclerosis	3.21e-06	2.66e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—INS—atherosclerosis	3.14e-06	2.61e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—atherosclerosis	2.88e-06	2.39e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NOS3—atherosclerosis	2.76e-06	2.29e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—atherosclerosis	2.73e-06	2.26e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.52e-06	2.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—atherosclerosis	2.36e-06	1.96e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—atherosclerosis	2.11e-06	1.75e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—atherosclerosis	1.94e-06	1.61e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—atherosclerosis	1.92e-06	1.59e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—atherosclerosis	1.64e-06	1.36e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—atherosclerosis	1.27e-06	1.05e-05	CbGpPWpGaD
